5-MeO-DiPT

5-MeO-DiPT

5-MeO-DiPT (5-Methoxy-N,N-diisopropyltryptamine) is a psychedelic and hallucinogenic drug, used recreationally for its psychoactive effects. It is part of the tryptamine class of drugs, which also includes substances like psilocybin, found in magic mushrooms, and DMT.

History

5-MeO-DiPT was first synthesized in 1979 by the chemist Alexander Shulgin, who documented his findings in the book TiHKAL (Tryptamines I Have Known and Loved). The drug gained popularity in the late 1990s and early 2000s as a legal alternative to other psychedelic substances.

Pharmacology

5-MeO-DiPT acts primarily as a serotonin receptor agonist. It binds to and activates the receptor, leading to an increased release of serotonin in the brain. This increase in serotonin levels is thought to be responsible for the drug's psychedelic effects.

Effects

The effects of 5-MeO-DiPT are similar to those of other tryptamines and can include visual and auditory hallucinations, altered perception of time, enhanced introspection, and increased emotional sensitivity. However, 5-MeO-DiPT is also known for its unique entactogenic effects, which can include feelings of empathy and emotional openness.

Legal Status

The legal status of 5-MeO-DiPT varies by country. In the United States, it is classified as a Schedule I drug under the Controlled Substances Act, meaning it is illegal to manufacture, distribute, or possess. In the United Kingdom, it is classified as a Class A drug under the Misuse of Drugs Act.

See Also

• Psychedelic drug
• Hallucinogen
• Tryptamine
• Serotonin receptor
• Schedule I drug